Cargando…

“Dual use”: The anti-allergy vaccine BM32 and its HBV carrier protein

Detalles Bibliográficos
Autor principal:	Gerlich, Wolfram H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516070/ https://www.ncbi.nlm.nih.gov/pubmed/32977164 http://dx.doi.org/10.1016/j.ebiom.2020.102998

Ejemplares similares

Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine
por: Gerlich, Wolfram H., et al.
Publicado: (2016)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Functional cure of chronic hepatitis B – predictable?
por: Gerlich, Wolfram
Publicado: (2021)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Contact allergy to aluminium induced by commonly used pediatric vaccines
por: Bergfors, E., et al.
Publicado: (2017)

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018)

Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy
por: Scognamiglio, Paola, et al.
Publicado: (2009)

HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020)

The Bm86 Discovery: A Revolution in the Development of Anti-Tick Vaccines
por: Rodríguez-Mallon, Alina
Publicado: (2023)

Do we need better hepatitis B vaccines?
por: Gerlich, Wolfram H.
Publicado: (2017)

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
por: Qi, Ruoyao, et al.
Publicado: (2023)

Interaction of Destruxin A with Three Silkworm Proteins: BmCRT, BmDPP3, and BmPDIA5
por: Yin, Xuyu, et al.
Publicado: (2022)

From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity
por: Osiowy, Carla
Publicado: (2018)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
por: Lim, Chee Kent, et al.
Publicado: (2006)

BmCBP Catalyzes the Acetylation of BmApoLp-II Protein and Regulates Its Stability in Silkworm, Bombyx mori
por: Chen, Yanmei, et al.
Publicado: (2023)

Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver–Specific in vivo Transfection Mouse Models—Pattern Recognition Receptors and Sensors for HBV
por: Leong, Chean Ring, et al.
Publicado: (2015)

Allergens are not pathogens: Why immunization against allergy differs from vaccination against infectious diseases
por: Weiss, Richard, et al.
Publicado: (2014)

RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
por: Rachner, Tilman D., et al.
Publicado: (2015)

BmTudor-sn Is a Binding Protein of Destruxin A in Silkworm Bm12 Cells
por: Wang, Jingjing, et al.
Publicado: (2019)

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
por: Tulaeva, Inna, et al.
Publicado: (2020)

Soothing signals: transplacental transmission of resistance to asthma and allergy
por: Holt, Patrick G., et al.
Publicado: (2009)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Intraocular Acrylic Allergy: Is it Something to Sneeze at?
por: Moshirfar, Majid, et al.
Publicado: (2021)

Doctor I Have an Iodine Allergy
por: Stewart, Michael W.
Publicado: (2022)

TSLP‐targeting therapy: Beyond allergy?
por: Ebina‐Shibuya, Risa, et al.
Publicado: (2023)

Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection
por: Arumugam, Sridhar, et al.
Publicado: (2016)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Allergy protection at farms—just a myth?
por: Wjst, Matthias
Publicado: (2020)

Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
por: Lee, Joon, et al.
Publicado: (2016)

Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
por: Hofmann, J., et al.
Publicado: (1997)

Early prevention instead of mending late damage in allergy?
por: Valenta, Rudolf
Publicado: (2019)

The global fight to develop antipoverty vaccines in the anti-vaccine era
por: Hotez, Peter J.
Publicado: (2018)

Aucubin promotes bone-fracture healing via the dual effects of anti-oxidative damage and enhancing osteoblastogenesis of hBM-MSCs
por: Wang, Kanbin, et al.
Publicado: (2022)

Transgenerational Epigenetic Inheritance Is Revealed as a Multi-step Process by Studies of the SET-Domain Proteins SET-25 and SET-32
por: Woodhouse, Rachel M, et al.
Publicado: (2019)

Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
por: Kaleli, Ilknur, et al.
Publicado: (2006)

Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance
por: Markovitz, Netana H., et al.
Publicado: (2022)

Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes
por: Wong, Robert J.
Publicado: (2021)

A model to predict liver damage in patients with HBeAg-positive chronic HBV infection
por: Maiocchi, Laura, et al.
Publicado: (2021)

Bmo-miR-2758 Targets BmFMBP-1 (Lepidoptera: Bombycidae) and Suppresses Its Expression in BmN Cells
por: Wang, Xin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s0ibmda362i6a3cle4fm8jhoa1